NSABP Biospecimen Discovery Project

UnknownOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2018

Study Completion Date

February 28, 2022

Conditions
Breast Cancer
Interventions
DRUG

Paclitaxel

BIOLOGICAL

trastuzumab

BIOLOGICAL

pertuzumab

Trial Locations (5)

10016

New York University School of Medicine, New York

15212

Allegheny General Hospital, Pittsburgh

32610

University of Florida, Gainesville

63110

Washington University School of Medicine, St Louis

77030

Baylor College of Medicine, Houston

Sponsors
All Listed Sponsors
collaborator

Breast Cancer Research Foundation

OTHER

collaborator

Washington University School of Medicine

OTHER

lead

NSABP Foundation Inc

NETWORK